Amogel: a multi-omics classification framework using associative graph neural networks with prior knowledge for biomarker identification.

The advent of high-throughput sequencing technologies, such as DNA microarray and DNA sequencing, has enabled effective analysis of cancer subtypes and targeted treatment. Furthermore, numerous studies have highlighted the capability of graph neural networks (GNN) to model complex biological systems and capture non-linear interactions in high-throughput data. GNN has proven to be useful in leveraging multiple types of omics data, including prior biological knowledge from various sources, such as transcriptomics, genomics, proteomics, and metabolomics, to improve cancer classification. However, current works do not fully utilize the non-linear learning potential of GNN and lack of the integration ability to analyse high-throughput multi-omics data simultaneously with prior biological knowledge. Nevertheless, relying on limited prior knowledge in generating gene graphs might lead to less accurate classification due to undiscovered significant gene-gene interactions, which may require expert intervention and can be time-consuming. Hence, this study proposes a graph classification model called associative multi-omics graph embedding learning (AMOGEL) to effectively integrate multi-omics datasets and prior knowledge through GNN coupled with association rule mining (ARM). AMOGEL employs an early fusion technique using ARM to mine intra-omics and inter-omics relationships, forming a multi-omics synthetic information graph before the model training. Moreover, AMOGEL introduces multi-dimensional edges, with multi-omics gene associations or edges as the main contributors and prior knowledge edges as auxiliary contributors. Additionally, it uses a gene ranking technique based on attention scores, considering the relationships between neighbouring genes. Several experiments were performed on BRCA and KIPAN cancer subtypes to demonstrate the integration of multi-omics datasets (miRNA, mRNA, and DNA methylation) with prior biological knowledge of protein-protein interactions, KEGG pathways and Gene Ontology. The experimental results showed that the AMOGEL outperformed the current state-of-the-art models in terms of classification accuracy, F1 score and AUC score. The findings of this study represent a crucial step forward in advancing the effective integration of multi-omics data and prior knowledge to improve cancer subtype classification.